Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
about
Natriuretic peptides for acute heart failureNatriuretic peptides for acute heart failureRE1-silencing transcription factor (REST) and REST-interacting LIM domain protein (RILP) affect P19CL6 differentiationN-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart diseaseScience review: natriuretic peptides in critical illnessClinical adoption of prognostic biomarkers: the case for heart failureThe clinical features of takotsubo cardiomyopathyScar myofibroblasts of the infarcted rat heart express natriuretic peptidesNatriuretic Peptide testing in primary careNatriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart.Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study.Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction.Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseasesGuanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic reviewResistance to cardiomyocyte hypertrophy in ae3-/- mice, deficient in the AE3 Cl-/HCO3- exchanger.NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in AfricaThe natriuretic peptides: physiology and role in left-ventricular dysfunction.Relationship between CCR and NT-proBNP in Chinese HF patients, and their correlations with severity of HF.Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure.The plasma B-type natriuretic peptide levels are low in males with stable ischemic heart disease (IHD) compared to those observed in patients with non-IHD: a retrospective studyHeart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General PopulationNovel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction.Hyper-Prolactinemia in Men With Idiopathic Dilated Cardiomyopathy: Does It Have any Prognostic Implications?Effect of valsartan on N-terminal pro-brain natriuretic Peptide in patient with stable chronic heart failure: comparison with enalaprilDesign of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation.Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failureThe role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting."BNP" for heart failure: role of nesiritide in cardiovascular therapeutics.Plasma B-type natriuretic peptide as a predictor of cardiovascular events in subjects with atrial fibrillation: a community-based studyRegulated inositol-requiring protein 1-dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure.Relationship between N-terminal pro-B-type natriuretic peptide and renal function: the effects on predicting early outcome after off-pump coronary artery bypass surgeryN-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy.Vitamin D deficiency contributes to the reduction and impaired function of naïve CD45RA⁺ regulatory T cell in chronic heart failureB-type natriuretic peptide: a new tool in the armamentarium used to accurately diagnose heart failure.Brain natriuretic peptide facilitates severity classification of stable chronic heart failure with left ventricular dysfunctionThe influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.
P2860
Q24194433-B2507D0D-F864-4CAD-A9F1-99486ADF6B49Q24245105-925A1292-C8FB-458B-80B6-29D7DD374C56Q24322741-480A45CE-B312-432C-BA2D-90A1BB3766E4Q24607043-D7A7E385-8444-499E-908E-186CA1CB98A7Q24799740-4952AAA5-C47C-4376-9D68-1C2892B62F20Q26863716-6BE1DC8E-BB09-4EAB-996A-B29A497F60E7Q28191673-76CFD629-050D-4401-A6A0-ABFBD207F330Q28565370-967EF873-40DC-40A1-B58A-749FAA9EB5F6Q33572286-970A5E2D-8D39-4ADF-961D-BABCC8B2D996Q33578038-E2F1114C-9C95-4D31-A8C0-315A63F3856CQ33644456-0EB5CB63-70AA-4AAF-948A-17590BE9E8F6Q33720841-7571D158-47B6-4E72-8D76-E12DED56AE57Q33738059-CDE9C4BA-1E40-43E6-8B59-41E47CDE53D3Q33792340-5EF08C0F-1382-48C1-9C55-F6827791C83DQ33932889-C5125C6B-EDCE-4B30-B56A-088345548DD4Q33994522-BD4DA713-8E36-4CBA-BD35-A3B177382BA5Q34009129-001789A8-1A97-42BC-A2CF-E4684D94355AQ34171357-2F2B3249-0508-448E-9643-2492744E42CBQ34183461-60F54130-E848-414F-BCE4-21BD0BFC3378Q34190826-4787B7FA-35A7-4894-B2A4-F947ED6BEB8BQ34297057-A6F0822B-D68A-4569-8562-1410EFAE4643Q34433995-50B3A66E-4D02-403D-AEE6-F630CCBB02EDQ34448373-F7054770-566D-4F92-84AE-27CA769124D7Q34512556-90CA136B-1246-41EE-88C3-6C25CEDE73EDQ34544890-48C464A6-75CF-4B53-9EAF-D50150D01FD1Q34566008-77399BD8-828E-4E1A-9E94-247D2352E3A3Q34621270-1BB2AB5E-9552-4AF4-978A-535414045200Q34648756-70311900-872F-45F0-BDF7-9564AF70FF0CQ34702418-283E0732-640F-45B3-8087-BDB5C2606C1BQ34771608-D0073742-253B-483F-8C36-0469ED7ED289Q34796770-B592FAD2-3625-4523-AC5A-AC48BEDA4DBDQ34943458-E0AB5739-9253-4831-9B0D-245DC17D7AA2Q35061214-C82591A6-952B-4A65-9497-D077F2C00789Q35114917-B62B5993-200D-4A93-A6AA-35A0739393DEQ35161498-44654F7D-DAEE-476D-97A9-EF2DA8BAEB0DQ35566711-7C113AE1-C6B2-4CE3-8B55-15644025AFD8Q35578732-50F4531E-7221-4F22-A4B3-F423FA3F66CCQ35578900-75D80040-B20A-467F-89B0-9C2C02DCFF39Q35581224-73CD9088-0AA6-4E64-90D4-B091FA405699Q35581313-DD3DAC3A-61B7-433C-BB53-8C54D45B8EA3
P2860
Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Attenuation of compensation of ...... left ventricular dysfunction.
@en
Attenuation of compensation of ...... left ventricular dysfunction.
@nl
type
label
Attenuation of compensation of ...... left ventricular dysfunction.
@en
Attenuation of compensation of ...... left ventricular dysfunction.
@nl
prefLabel
Attenuation of compensation of ...... left ventricular dysfunction.
@en
Attenuation of compensation of ...... left ventricular dysfunction.
@nl
P2093
P356
P1433
P1476
Attenuation of compensation of ...... left ventricular dysfunction.
@en
P2093
Hisanaga T
Kinoshita M
Sugimoto Y
Tsutamoto T
P304
P356
10.1161/01.CIR.96.2.509
P407
P577
1997-07-01T00:00:00Z